Chronic Pain Clinical Trial
— EAPER-POfficial title:
Early Accessible Person-centred Rehabilitation With the Focus on Return to Work for Patients With Chronic Pain (EAPER-P)
NCT number | NCT04706195 |
Other study ID # | EAPER-P |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | August 15, 2021 |
Est. completion date | March 15, 2028 |
The goal of the research project EAPER-P is to evaluate PCC person-centred care (PCC) in the form of a combined eHealth and telephone support for patents with chronic pain. A developed PCC eHealth platform, together with person-centred telephone conversations, will be used as a tool to identify patients´ resources to enhance coping and living with their illness by means of a dialog and partnership with staff and relatives. PCC in the form of a combined eHealth and telephone support will not replace, but instead be used as add on treatment to usual care (guideline directed care). In addition, a process evaluation of the intervention will be performed in order to evaluate the mechanisms behind the intervention and evaluate which parts of the interventions the participants find useful.
Status | Recruiting |
Enrollment | 220 |
Est. completion date | March 15, 2028 |
Est. primary completion date | August 15, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Men and women 18-65 years old. - Living with chronic, non-malignant, pain with any of the following diagnoses: M25, M54, M79 and R52 - On sick leave (full or part time) from paid professional work. - Willing to participate Exclusion Criteria: - Full time sick leave >24 months (part time sick leave >24 months can be included). - Severe impairment (cognitive or other) that prevents patient from using the eHealth support - No registered address - Not willing to participate - Any severe disease with an expected survival <12 months - Ongoing documented diagnosis of alcohol or drug abuse - Other severe disease that can interfere with follow-up or if the intervention is assessed as a burden - Patient participating in another conflicting randomized study - Patients not understanding spoken and written Swedish - Patient not having access to a device with internet access |
Country | Name | City | State |
---|---|---|---|
Sweden | Primary care | Gothenburg |
Lead Sponsor | Collaborator |
---|---|
Göteborg University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Composite score of changes | A patient is classified as improved, deteriorated or unchanged:
A patient is classified as improved if: at 6 months reduced sick leave and increased General self-efficacy scale by = 5 units A patient is classified as deteriorated if: at 6 months increased sick leave or (if on full-time sick leave at inclusion reduced general self-efficacy by = 5 units) Those who have neither deteriorated nor improved are considered unchanged General Self-Efficacy Scale: Possible scores range from 10 (low self-efficacy, worst) to 40 (high self-efficacy). Composite score possible scores: deteriorated (worst), unchanged, improved (best). |
Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Sick leave | Grade of sick leave Possible scores range from 0% (best) to 100% (worst) | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | General self-efficacy scale | Questionnaire General Self-Efficacy Scale: Possible scores range from 10 (low self-efficacy, worst) to 40 (high self-efficacy). | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | EuroQol- 5 Dimensions (EQ-5D) | Questionnaire
Possible scores on the different dimensions: Mobility I have no problems in walking about (best) I have some problems in walking about I am confined to bed (worst) Self-care I have no problems with self-care (best) I have some problems washing or dressing myself I am unable to wash or dress myself (worst) Usual activities (e.g. work, study, housework, family or leisure activities) I have no problems with performing my usual activities (best) I have some problems with performing my usual activities I am unable to perform my usual activities (worst) Pain/discomfort I have no pain or discomfort (best) I have moderate pain or discomfort I have extreme pain or discomfort (worst) Anxiety/depression I am not anxious or depressed (best) I am moderately anxious or depressed I am extremely anxious or depressed (worst) EQ-5D Visual Analog Scale (VAS) Possible range: 0 (the worst health you can imagine) to 100 (the best health you can imagine) |
Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Hospital anxiety and depression scale (HADS) | Questionnaire Total score possible range: 0 (best) to 42 (worst) Sub-scale depression possible range 0 (best) to 21 (worst) Sub-scale anxiety possible range 0 (best) to 21 (worst) | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Number of health care visits (Health care utilization) | Health care utilization, data from registry where individual use of health care is recorded. Number of visits to health care. Ranges from 0 visits (best) and up. There is no maximum number of possible visits. More visits are worse. | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Cost of health care utilized | Health care utilization, data from registry where individual use of health care is recorded. Cost of health care visits ranges $0 (best) and up.There is no maximum cost of possible visits. Higher costs are worse. | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Incremental cost-utility ratios | Incremental cost-utility ratios | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Tampa scale of kinesiophobia (TSK-SV) Possible score range from 17 (best) to 68 (worst) | Questionnaire | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Pain Disability Index (PDI) | Questionnaire Possible score range from 0 (best) to 70 (worst) | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Insomnia Severity Index (ISI) | Questionnaire Possible score range from 0 (best) to 28 (worst) | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Physical activity according to the Swedish National Board of Health and Welfare | Questionnaire Physical exercise possible range 0 (0 minutes of / week) to 6 (>120 minutes / week) Everyday physical activity possible range: 0 (0 minutes of / week) to 7 (>300 minutes / week) | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | Numeric Rating Scale for Pain (NRS Pain) | Questionnaire At rest possible score 0 (no pain) to 10 (worst possible pain) In motion possible score 0 (no pain) to 10 (worst possible pain) | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. | |
Secondary | The Being Taken Seriously Questionnaire | Questionnaire Possible score 6 (worst) to 48 (best) | Baseline, 3 months, 6 months, 1 year, 2 years, 5 years. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|